Opposing effects of tumour necrosis factor α and hyperosmolarity on Na+/myo-inositol co-transporter mRNA levels and myo-inositol accumulation by 3T3-L1 adipocytes

被引:9
|
作者
Yorek, MA [1 ]
Dunlap, JA
Lowe, WL
机构
[1] Univ Iowa, Diabet Endocrinol Res Ctr, Dept Internal Med, Iowa City, IA 52246 USA
[2] Vet Affairs Med Ctr, Iowa City, IA 52246 USA
[3] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[4] Vet Affairs Chicago Healthcare Syst Lakeside Div, Chicago, IL 60611 USA
关键词
D O I
10.1042/bj3360317
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumour necrosis factor alpha (TNF-alpha) regulates the transport of myo-inositol in 3T3-L1 adipocytes. Treating 3T3-L1 adipocytes with TNF-alpha decreases Na+/myo-inositol co-transporter (SMIT) mRNA levels and myo-inositol accumulation in a concentration- and time-dependent manner. TNF-alpha decreases the V'(max) for high-affinity myo-inositol transport with little change in the K'(m). Studies with actinomycin D suggest that RNA synthesis is required for the TNF-alpha-induced effect on SMIT mRNA levels. In contrast with the effect of TNF-alpha, hyperosmolarity increases SMIT mRNA levels and myo-inositol accumulation in 3T3-L1 adipocytes. Hyperosmolarity increases SMIT gene expression as evidenced by the inhibition of hyperosmotic induction of SMIT mRNA levels by actinomycin D, and of myo-inositol accumulation by actinomycin D and cycloheximide. TNF-alpha and osmotic stress have previously been shown to activate similar signal transduction pathways in mammalian cells. In 3T3-L1 adipocytes, both TNF-alpha and hyperosmolarity increase mitogen-activated protein kinase kinase pathway activity; however, with the possible exception of c-Jun N-terminal kinase, this pathway does not seem to regulate SMIT mRNA levels or myo-inositol accumulation. TNF-alpha activates nuclear factor kappa B (NF-KB) in 3T3-L1 adipocytes but, unlike the effect of TNF-alpha. on cultured endothelial cells, NF-kappa B does not seem to contribute to the regulation by TNF-alpha of SMIT gene expression in 3T3-L1 adipocytes. Therefore other signal transduction pathways must be considered in the regulation by TNF-alpha of SMIT mRNA levels and activity. Thus TNF-alpha and hyperosmolarity have opposing effects on SMIT mRNA levels and activity in 3T3-L1 adipocytes, Because myo-inositol in the form of phosphoinositides is an important component of membranes and signal transduction pathways, the regulation of myo-inositol metabolism by TNF-alpha might represent another mechanism by which TNF-alpha regulates adipocyte function.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 50 条
  • [21] 1D-MYO-INOSITOL 1,4,5-TRISPHOSPHATE AND 1D-MYO-INOSITOL 1,3,4,5-TETRAKISPHOSPHATE ANALOGS MODIFIED AT C-3 - SYNTHESIS OF 1D-3-C-(TRIFLUOROMETHYL)-MYO-INOSITOL 1,4,5-TRISPHOSPHATE AND 1L-CHIRO-INOSITOL 1,2,3,5-TETRAKISPHOSPHATE FROM L-QUEBRACHITOL
    KOZIKOWSKI, AP
    OGNYANOV, VI
    FAUQ, AH
    WILCOX, RA
    NAHORSKI, SR
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1994, (05) : 599 - 600
  • [22] Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: Myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain
    Buccafusca, Roberto
    Venditti, Charles P.
    Kenyon, Lawrence C.
    Johanson, Roy A.
    Van Bockstaele, Elisabeth
    Ren, Jun
    Pagliardini, Silvia
    Minarcik, Jeremy
    Golden, Jeffrey A.
    Coady, Michael J.
    Greer, John J.
    Berry, Gerard T.
    MOLECULAR GENETICS AND METABOLISM, 2008, 95 (1-2) : 81 - 95
  • [23] Co-suppression of AtMIPS demonstrates cooperation of MIPS1, MIPS2 and MIPS3 in maintaining myo-inositol synthesis
    C. M. Fleet
    J. Y. Yen
    E. A. Hill
    G. E. Gillaspy
    Plant Molecular Biology, 2018, 97 : 253 - 263
  • [24] Co-suppression of AtMIPS demonstrates cooperation of MIPS1, MIPS2 and MIPS3 in maintaining myo-inositol synthesis
    Fleet, C. M.
    Yen, J. Y.
    Hill, E. A.
    Gillaspy, G. E.
    PLANT MOLECULAR BIOLOGY, 2018, 97 (03) : 253 - 263
  • [25] Synthesis of D- and L-myo-inositol 1,2,4,6-tetrakisphosphate, regioisomers of myo-inositol 1,3,4,5 tetrakisphosphate:: activity against Ins(1,4,5)P3 binding proteins
    Mills, SJ
    Backers, K
    Erneux, C
    Potter, BVL
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (20) : 3546 - 3556
  • [26] A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain
    Srinivasan, R
    Vigneron, D
    Sailasuta, N
    Hurd, R
    Nelson, S
    MAGNETIC RESONANCE IMAGING, 2004, 22 (04) : 523 - 528
  • [27] Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an in vivo 1H-MRS study
    McNamara, Robert K.
    Able, Jessica
    Jandacek, Ronald
    Rider, Therese
    Tso, Patrick
    Lindquist, Diana M.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (03) : 405 - 411
  • [28] The 21q22.1 STS marker, VN02 (EST00541 cDNA), is part of the 3' sequence of the human Na+/myo-inositol cotransporter (SLC5A3)
    Berry, GT
    Mallee, JJ
    Blouin, JL
    Antonarakis, SE
    CYTOGENETICS AND CELL GENETICS, 1996, 73 (1-2): : 77 - 78
  • [29] Inframolecular acid-base and coordination properties towards Na+ and Mg2+ of myo-inositol 1,3,4,5,6-pentakisphosphate: a structural approach to biologically relevant species
    Veiga, Nicolas
    Torres, Julia
    Macho, Israel
    Gomez, Kerman
    Godage, Himali Y.
    Riley, Andrew M.
    Potter, Barry V. L.
    Gonzalez, Gabriel
    Kremer, Carlos
    DALTON TRANSACTIONS, 2013, 42 (17) : 6021 - 6032
  • [30] Murine chromosome 16 telomeric region, homologous with human chromosome 21q22, contains the osmoregulatory Na+/myo-inositol cotransporter (SLC5A3) gene
    McVeigh, KE
    Mallee, JJ
    Lucente, A
    Barnoski, BL
    Wu, S
    Berry, GT
    CYTOGENETICS AND CELL GENETICS, 2000, 88 (1-2): : 153 - 158